Get started
Author

Laura Eurelings

Observed names: Eurelings, Laura, L E M Eurelings, L. E. M. Eurelings, Laura E M Eurelings, Laura E. M. Eurelings, Laura E.M. Eurelings, Laura Elisabeth Maria Eurelings
ORCID: 0000-0002-1830-2213
Observed ORCID: 0000-0002-1830-2213
OpenAlex ID: A5043677389
Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis
2019 · Laura E. M. Eurelings, Jelle R. Miedema, et al. · PLoS ONE · 125
PDF
Diagnostic Value of Serum-Soluble Interleukin 2 Receptor Levels vs Angiotensin-Converting Enzyme in Patients With Sarcoidosis-Associated Uveitis
2017 · Fahriye Groen-Hakan, Laura Eurelings, et al. · JAMA Ophthalmology · 57
PDF
Soluble Interleukin-2 Receptor: A Potential Marker for Monitoring Disease Activity in IgG4-Related Disease
2018 · A. F. Karim, L. E. M. Eurelings, et al. · Mediators of Inflammation · 46
PDF
The association between allergic diseases and cancer: a systematic review of the literature.
2019 · A F Karim, L E H Westenberg, et al. · PubMed · 34
Long-Term Follow-up of Patients With Uveitis Treated With Adalimumab: Response Rates and Reasons for Discontinuation of Therapy
2022 · Laura E.M. Eurelings, Tom O.A.R. Missotten, et al. · American Journal of Ophthalmology · 32
PDF
Relevance of erythrocyte sedimentation rate and C-reactive protein in patients with active uveitis
2018 · Fahriye Groen-Hakan, Laura Eurelings, et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 18
PDF
Lymphopaenia as a predictor of sarcoidosis in patients with a first episode of uveitis
2018 · Fahriye Groen-Hakan, Laura Eurelings, et al. · British Journal of Ophthalmology · 15
Venetoclax combinations in untreated CLL: 5-year results and patient-reported outcomes analysis of the CLL13/GAIA trial
2026 · Moritz Fürstenau, Carsten U. Niemann, et al. · Blood · 9
Implications of Elevated C‐Reactive Protein and Serum Amyloid A Levels in IgG4‐Related Disease: Comment on the Article by Perugino et al
2017 · A. Faiz Karim, Laura E. M. Eurelings, et al. · Arthritis & Rheumatology · 5
Patient-Reported Quality of Life Outcomes with Venetoclax-Based First-Line Combinations in CLL: An Analysis from the Phase 3 GAIA/CLL13 Trial
2024 · Moritz Fürstenau, Emelie Curovic Rotbain, et al. · Blood · 2
PDF
Quality of Life in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Improves after Minimal Residual Disease-Guided Treatment with Ibrutinib Plus Venetoclax
2024 · Laura Elisabeth Maria Eurelings, Emelie Curovic Rotbain, et al. · Blood · 2
Serum Angiotensin-Converting Enzyme Has a High Negative Predictive Value in the Investigation for Systemic Sarcoidosis
2019 · Fahriye Groen-Hakan, Laura Eurelings · American Journal of Ophthalmology · 1
MRD-guided ibrutinib plus venetoclax improves quality of life in relapsed/refractory CLL: HOVON 141/VISION trial results
2026 · Laura Elisabeth Maria Eurelings, Emelie Curovic Rotbain, et al. · Blood Advances
Phenotype, treatment, and determinants of prognosis in Erdheim–Chester disease: an international, retrospective, cohort study
2026 · Francesco Pegoraro, Francesco Peyronel, et al. · The Lancet Haematology
Clinical presentation and prognosis in erdheim-chester disease: Analysis of an international cohort of 1044 patients within the ecdga network
2025 · Francesco Pegoraro, Francesco Peyronel, et al. · Blood
Works count: 17
Citation count: 346
H-index: 8
I10-index: 7
Year
Topic
Type